Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Director departure
|
Odonate Therapeutics, Inc. (ODT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
11/26/2021 |
SC 13D/A
| Boxer Capital, LLC reports a 10.9% stake in Odonate Therapeutics, Inc. |
11/22/2021 |
SC 13D/A
| Boxer Capital, LLC reports a 12% stake in Odonate Therapeutics, Inc. |
11/19/2021 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 33.7% stake in Odonate Therapeutics, Inc. |
12/29/2020 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 41.6% stake in Odonate Therapeutics, Inc. |
09/01/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
09/01/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
10/02/2019 |
SC 13D/A
| Odonate Holdings, LLC reports a 4.8% stake in Odonate Therapeutics, Inc. |
06/28/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
03/12/2019 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 52.9% stake in Odonate Therapeutics, Inc. |
12/27/2018 |
SC 13D/A
| Boxer Capital, LLC reports a 11.1% stake in Odonate Therapeutics, Inc. |
11/09/2018 |
SC 13D/A
| Odonate Holdings, LLC reports a 8.7% stake in Odonate Therapeutics, Inc. |
11/09/2018 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 51.6% stake in Odonate Therapeutics, Inc. |
|
|